Navigation
Navigation
User login
Description of the image

References

Description of the image
  1.  UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer 2000; 82: 1073–102.
  2. McKinney PA, Juszczak E, Findlay E, Smith K. Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K. BMJ 1998; 316: 173–7.
  3. Day N, Skinner J, Roman E, Allen SG, Maslanyj MP, Mee TJ. Exposure to power-frequency magnetic fields and the risk of childhood cancer. UK Childhood Cancer Study Investigators. Lancet 1999; 354: 1925–31.
  4. Ahlbom A, Day N, Feychting M, et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer 2000; 83: 692–8.
  5. Skinner J, Maslanyj M, Mee TJ, et al. Childhood cancer and residential proximity to power lines. UK Childhood Cancer Study Investigators. Br J Cancer 2000; 83: 1573–80.
  6. Roman E, Fear NT, Ansell P, et al. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer 2002; 86: 63–9.
  7. Skinner J, Mee TJ, Blackwell RP, et al. Exposure to power frequency electric fields and the risk of childhood cancer in the UK. Br J Cancer 2002; 87: 1257–66.
  8. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas. Br J Cancer 2002; 86: 1721–6.
  9. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation. Br J Cancer 2002; 86: 1727–31.
  10. Fear NT, Roman E, Ansell P, Simpson J, Day N, Eden OB. Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Br J Cancer 2003; 89: 1228–31.
  11. McKinney PA, Fear NT, Stockton D. Parental occupation at periconception: findings from the United Kingdom Childhood Cancer Study. Occup Env Med 2003; 60: 901–9.
  12. Pang D, McNally R, Birch JM. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. Br J Cancer 2003; 88: 373–81.
  13. Day N, Eden T, McKinney P, Roman E, Simpson J. Childhood cancer and power lines: What do the data mean? BMJ 2005; 331: 634–7.
  14. Maslanyj M, Mee TJ, Allen SG. Investigation and Identification of Sources of Residential Magnetic Field Exposures in the United Kingdom Childhood Cancer Study (UKCCS). Radiation Protection Division. Health Protection Agency, 2005.
  15. Maslanyj MP, Mee TJ, Renew DC, et al. Investigation of the sources of residential power frequency magnetic field exposure in the UK Childhood Cancer Study. J Radiol Prot 2007; 27: 41–58.
  16. Roman E, Simpson J, Ansell P, et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 2007; 165: 496–504.
  17. Schüz J, Svendsen AL, Linet MS, et al. Nighttime exposure to electromagnetic fields and childhood leukemia: an extended pooled analysis. Am J Epidemiol 2007; 166: 263–9.
  18. Simpson J, Smith A, Ansell P, Roman E. Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer 2007; 43: 2396–403.
  19. McKinney PA, Raji OY, van Tongeren M, Feltbower RG. The UK Childhood Cancer Study: maternal occupational exposures and childhood leukaemia and lymphoma. Radiat Prot Dosim 2008; 132: 232–40.
  20. Maslanyj M, Simpson J, Roman E, Schüz J. Power frequency magnetic fields and risk of childhood leukaemia: misclassification of exposure from the use of the ‘distance from power line’ exposure surrogate. Bioelectromagnetics 2009; 30: 183–8.
  21. Roman E, Simpson J, Ansell P, Lightfoot T, Smith A. Infectious proxies and childhood leukaemia: findings from the United Kingdom Childhood Cancer Study (UKCCS). Blood Cells Mol Dis 2009; 42: 126–8.
  22. Kheifets L, Ahlbom A, Crespi CM, et al. A pooled analysis of extremely low-frequency magnetic fields and childhood brain tumors. Am J Epidemiol 2010; 172: 752–61.
  23. Rajaraman P, Simpson J, Neta G, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. BMJ 2011; 342: 1756–833.
  24. Crouch S, Lightfoot T, Simpson J, Smith A, Ansell P, Roman E. Infectious illness in children subsequently diagnosed with acute lymphoblastic leukemia: modeling the trends from birth to diagnosis. Am J Epidemiol 2012; 176: 402–8.
  25. Bailey HD, Fritschi L, Infante-Rivard C, et al. Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: findings from the Childhood Leukemia International Consortium. Int J Cancer 2014; 135: 2157–72.
  26. Bailey HD, Fritschi L, Metayer C, et al. Parental occupational paint exposure and risk of childhood leukemia in the offspring: findings from the Childhood Leukemia International Consortium. Cancer Causes Control 2014; 25: 1351–67.
  27. Huoi C, Olsson A, Lightfoot T, et al. Parental occupational exposure and risk of childhood central nervous system tumors: a pooled analysis of case-control studies from Germany, France, and the UK. Cancer Causes Control 2014; 25: 1603–13.
  28. Bailey HD, Infante-Rivard C, Metayer C, et al. Home pesticide exposures and risk of childhood leukemia: Findings from the Childhood Leukemia International Consortium. Int J Cancer 2015; 137: 2644–63.
  29. Bonaventure A, Simpson J, Ansell P, Roman E, Lightfoot T. Prescription drug use during pregnancy and risk of childhood cancer – Is there an association? Cancer Epidemiol 2015; 39: 73–8.
  30. Febvey O, Schüz J, Bailey HD, et al. Risk of Central Nervous System Tumors in Children Related to Parental Occupational Pesticide Exposures in three European Case-Control Studies. J Occup Environ Med 2016; 58: 1046–52.
  31. Metayer C, Petridou E, Aranguré JMM, et al. Parental Tobacco Smoking and Acute Myeloid Leukemia: The Childhood Leukemia International Consortium. Am J Epidemiol 2016; 184: 261–73.
  32. McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 1999; 80: 1844–51.
  33. Beral V, Fear NT, Alexander F, Appleby, P. Breastfeeding and childhood cancer. Br J Cancer 2001; 85: 1685–94.
  34. Fear NT, Roman E, Ansell P, Bull D. Malignant neoplasms of the brain during childhood: the role of prenatal and neonatal factors (United Kingdom). Cancer Causes Control 2001; 12: 443–9.
  35. Fear NT, Roman E. Re: Breast-feeding and neuroblastoma, USA and Canada. Cancer Causes Control 2003; 14: 299.
  36. Ansell P, Mitchell CD, Roman E, Simpson J, Birch JM, Eden TOB. Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. Eur J Cancer 2005; 41: 741–8.
  37. Roman E, Simpson J, Ansell P, Lightfoot T, Mitchell C, Eden TOB. Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer 2005; 41: 749–59.
  38. Roman E, Doyle P, Lightfoot T, et al. Molar pregnancy, childhood cancer and genomic imprinting - is there a link? Hum Fertil 2006; 9: 171–4.
  39. Harding NJ, Birch JM, Hepworth SJ, McKinney PA, UKCCS Investigators. Breastfeeding and risk of childhood CNS tumours. Br J Cancer 2007; 96: 815–7.
  40. Hughes AM, Lightfoot T, Simpson J, et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 2007; 121: 819–24.
  41. Harding NJ, Birch JM, Hepworth SJ, McKinney PA. Atopic dysfunction and risk of central nervous system tumours in children. Eur J Cancer 2008; 44: 92–9.
  42. Hughes AM, Crouch S, Lightfoot T, Ansell P, Simpson J, Roman E. Eczema, birth order, and infection. Am J Epidemiol 2008; 167: 1182–7.
  43. Smith A, Lightfoot T, Simpson J, Roman E. Birth weight, sex and childhood cancer: A report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 2009; 33: 363–7.
  44. Milne E, Greenop KR, Metayer C, et al. Fetal growth and childhood acute lymphoblastic leukemia: Findings from the Childhood Leukemia International Consortium. Int J Cancer 2013; 133: 2968–79.
  45. Roman E, Lightfoot T, Smith AG, et al. Childhood acute lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United States. Eur J Cancer 2013; 49: 1437–47.
  46. Metayer C, Milne E, Clavel J, et al. The Childhood Leukemia International Consortium. Cancer Epidemiol 2013; 37: 336–47.
  47. Law GR, Smith AG, Roman E. The importance of full participation: lessons from a national case-control study. Br J Cancer 2002; 86: 350–5.
  48. Law GR, Parslow RC, Roman E. Childhood cancer and population mixing. Am J Epidemiol 2003; 158: 328–36.
  49. Smith A, Roman E, Simpson J, Ansell P, Fear NT, Eden T. Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom Childhood Cancer Study (UKCCS). Int J Epidemiol 2006; 35: 1504–13.
  50. Smith A, Lightfoot T, Roman E. Comment on ‘Childhood leukaemia and socioeconomic status in England and Wales 1976-2005: evidence of higher incidence in relatively affluent communities persists over time’. Br J Cancer 2012; 107: 217-218 author reply 219-220.
  51. Ansell P, Johnston T, Simpson J, Crouch S, Roman E, Picton S. Brain Tumor Signs and Symptoms: Analysis of Primary Health Care Records From the UKCCS. Pediatrics 2010; 125: 112–9.
  52. Johnston WT, Lightfoot TJ, Simpson J, Roman E. Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 2010; 34: 659–66.
  53. Lightfoot TJ, Johnston WT, Simpson J, et al. Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom. Eur J Cancer 2012; 48: 263–9.
  54. Schüz J, Grell K, Kinsey S, et al. Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. Blood Cancer J 2012; 2: e98.
  55. Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999; 354: 1499–503.
  56. Wiemels JL, Alexander FE, Cazzaniga G, Biondi A, Mayer SP, Greaves M. Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2000; 29: 219–28.
  57. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci 2001; 98: 4004–9.
  58. Taylor GM, Dearden S, Ravetto P, et al. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Hum Mol Genet 2002; 11: 1585–97.
  59. Taylor GM, Hussain A, Lightfoot TJ, Birch JM, Eden TOB, Greaves MF. HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes. Br J Cancer 2008; 98: 1125–31.
  60. Taylor M, Harrison C, Eden T, et al. HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention. Cancer Immunol Immunother CII 2008; 57: 53–61.
  61. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006–10.
  62. Taylor GM, Hussain A, Verhage V, et al. Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601. Leukemia 2009; 23: 863–9.
  63. Taylor GM, Richards S, Wade R, et al. Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease? Br J Haematol 2009; 145: 87–95.
  64. Taylor M, Hussain A, Urayama K, et al. The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. Blood Cells Mol Dis 2009; 42: 129–35.
  65. Hosking FJ, Papaemmanuil E, Sheridan E, et al. Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk. Blood 2010; 115: 4472–7.
  66. Lightfoot TJ, Johnston WT, Painter D, et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 2010; 115: 3923–9.
  67. Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010; 115: 1765–7.
  68. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010; 42: 492–4.
  69. Hosking FJ, Leslie S, Dilthey A, et al. MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia. Blood 2011; 117: 1633–40.
  70. Sherborne AL, Hemminki K, Kumar R, et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica 2011; 96: 1049–54.
  71. Enciso-Mora V, Hosking FJ, Sheridan E, et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 2012; 26: 2212–5.
  72. Migliorini G, Fiege B, Hosking FJ, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood 2013; 122: 3298–307.
  73. Thompson P, Urayama K, Zheng J, et al. Differences in meiotic recombination rates in childhood acute lymphoblastic leukemia at an MHC class II hotspot close to disease associated haplotypes. PloS One 2014; 9: e100480.
  74. Vijayakrishnan J, Henrion M, Moorman AV, et al. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A. Sci Rep 2015; 5: 15065.
  75. Vijayakrishnan J, Kumar R, Henrion MYR, et al. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1. Leukemia 2017; 31: 573–9.
  76. Jenkinson CM, Muir KM, Hawtin PG, Chilvers CE. Attitudes and impressions of participants in a study of the causes of childhood cancer. Br J Cancer 2001; 84: 413–6.
  77. Ansell P, Roman E, Fear N, Simpson J, Day N, Eden T. Vitamin K update: survey of paediatricians in the UK. Br J Midwifery 2004; 12: 38–41.
  78. Fear NT, Simpson J, Roman E, United Kingdom Childhood Cancer Study Investigators. Childhood cancer and social contact: the role of paternal occupation (United Kingdom). Cancer Causes Control 2005; 16: 1091–7.
  79. Gilham C, Peto J, Simpson J, et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ 2005; 330: 1294.
  80. Harding NJ, Birch JM, Hepworth SJ, McKinney PA. Infectious exposure in the first year of life and risk of central nervous system tumors in children: analysis of day care, social contact, and overcrowding. Cancer Causes Control 2009; 20: 129–36.
  81. Rudant J, Lightfoot T, Urayama KY, et al. Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study. Am J Epidemiol 2015; 181: 549–62.
  82. Thun M, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors. Cancer Epidemiology and Prevention, New Edition, Fourth Edition. Oxford, New York: Oxford University Press, 2018.
  83. Berrington de González A, Morton LM. Converting epidemiologic studies of cancer etiology to survivorship studies: approaches and challenges. Cancer Epidemiol Biomarkers Prev 2012; 21: 875–80.
  84. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/ based on November 2014 SEER data submission, posted to the SEER web site, April 2015. 2014 http://seer.cancer.gov/csr/1975_2012/.
  85. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-386.
  86. National Vital Statistics System, National Center for Health Statistics, Centers for Disease Control and Prevention. Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in 5-year Age Groups, by Race and Sex: United States, 1999-2014. https://www.cdc.gov/nchs/nvss/mortality/lcwk1.htm (accessed Feb 9, 2017).
  87. Office for National Statistics. What are the top causes of death by age and gender? Part of Mortality Statistics: Deaths Registered in England and Wales (Series DR), 2012 Release. http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics--deaths-registered-in-england-and-wales--series-dr-/2012/sty-causes-of-death.html (accessed Feb 9, 2017).
  88. Elena JW, Travis LB, Simonds NI, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst 2013; 105: 85–94.
  89. Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol 2014; 15: 35–47.
  90. American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society, 2015 http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf.
  91. The European Society for Paediatric Oncology. The SIOPE Strategic Plan. A European Cancer Plan for Children and Adolescents. SIOP Europe, 2015 http://www.siope.eu/SIOPE_StrategicPlan2015/#.
  92. Kebudi R, Özdemir GN. Second malignant neoplasms in childhood cancer survivors. Curr Pediatr Rev 2017; 13: 34–41.
  93. Fidler MM, Reulen RC, Henson KE, et al. Population-Based Long-Term Cardiac-Specific Mortality Among 34,489 Five-Year Survivors of Childhood Cancer in Great Britain. Circulation 2017; 135: 951–63.
  94. Dietz AC, Chen Y, Yasui Y, et al. Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 2016; 122: 3687–96.
  95. Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJL, Lambalk CB, van Dulmen-den Broeder E. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review. Cancer Treat Rev 2017; 53: 10–24.
  96. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 2002; 38: 229–39.
  97. Shaw AK, Morrison HI, Speechley KN, et al. The late effects study: design and subject representativeness of a Canadian, multi-centre study of late effects of childhood cancer. Chronic Dis Can 2004; 25: 119–26.
  98. McBride ML, Rogers PC, Sheps SB, et al. Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristics. Pediatr Blood Cancer 2010; 55: 324–30.
  99. Winther JF, Kenborg L, Byrne J, et al. Childhood cancer survivor cohorts in Europe. Acta Oncol 2015; 54: 655–68.
  100. van Laar M, Feltbower RG, Gale CP, Bowen DT, Oliver SE, Glaser A. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study. Br J Cancer 2014; 110: 1338–41.